Empagliflozin compared with glimepiride in metformin ‐treated patients with type 2 diabetes: 208‐week data from a masked randomized controlled trial

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - July 2, 2018 Category: Endocrinology Authors: Martin Ridderstr åle MD , Julio Rosenstock MD , Knut Robert Andersen BSc , Hans J. Woerle MD , Afshin Salsali MD , Source Type: research